Status:
RECRUITING
VExUS Combined With CVP to Predict Clinical Outcomes in Sepsis Participants
Lead Sponsor:
The Second People's Hospital of Yibin
Conditions:
Sepsis
Acute Kidney Injury
Eligibility:
All Genders
18-100 years
Brief Summary
Introduction: Sepsis is a life-threatening organ dysfunction caused by a dysregulated host immune response to infection, and it is a common critical condition in the ICU. Early and timely fluid resus...
Detailed Description
Study Title: Association between VExUS Score Combined with CVP and Prediction of Clinical Outcomes in Septic participants: A Multicenter, Prospective, Observational Study. Study Objective: To inves...
Eligibility Criteria
Inclusion
- Adult participants (age ≥ 18 years) with sepsis upon admission or during their stay in the ICU.
Exclusion
- Age \< 18 years
- Participants admitted to the ICU for \< 24 hours
- Pregnant or lactating women
- Severe renal impairment (defined as baseline estimated glomerular filtration rate \< 15 mL/min or requiring regular dialysis), including causes such as urinary tract obstruction, contrast agents, or nephrotoxic drugs
- Liver cirrhosis with portal hypertension
- Presence of urinary tract obstruction (which may affect IRVF waveform)
- Inability to resolve the primary disease
- Participants receiving palliative care
- Inability to obtain ultrasound images
- Inability to monitor CVP
- Refusal of monitoring by participants or their families
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06524622
Start Date
July 1 2024
End Date
January 31 2025
Last Update
July 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Point-of-care ultrasound (POCUS)
Yibin, Sichuan, China, 610000